Matches in Nanopublications for { ?s ?p ""* [see Drug Interactions ( 7 12.3 * LEXIVA is contraindicated when coadministered with the following drugs: o Alpha 1-adrenoreceptor antagonist: Alfuzosin o Antiarrhythmics: Flecainide (with ritonavir), propafenone (with ritonavir) o Antimycobacterial: Rifampin o Antipsychotic: Lurasidone (with ritonavir), pimozide o Ergot derivatives: Dihydroergotamine, ergonovine, ergotamine, methylergonovine o GI motility agent: Cisapride o Herbal product: St. John's wort ( Hypericum perforatum o Lipid modifying agents: Lomitapide, lovastatin, simvastatin o Non-nucleoside reverse transcriptase inhibitor: Delavirdine o PDE5 inhibitor: Sildenafil (REVATIO) (for treatment of pulmonary arterial hypertension) o Sedative/hypnotics: Midazolam, triazolam * 4 * 4 * 4"" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- association label ""* [see Drug Interactions ( 7 12.3 * LEXIVA is contraindicated when coadministered with the following drugs: o Alpha 1-adrenoreceptor antagonist: Alfuzosin o Antiarrhythmics: Flecainide (with ritonavir), propafenone (with ritonavir) o Antimycobacterial: Rifampin o Antipsychotic: Lurasidone (with ritonavir), pimozide o Ergot derivatives: Dihydroergotamine, ergonovine, ergotamine, methylergonovine o GI motility agent: Cisapride o Herbal product: St. John's wort ( Hypericum perforatum o Lipid modifying agents: Lomitapide, lovastatin, simvastatin o Non-nucleoside reverse transcriptase inhibitor: Delavirdine o PDE5 inhibitor: Sildenafil (REVATIO) (for treatment of pulmonary arterial hypertension) o Sedative/hypnotics: Midazolam, triazolam * 4 * 4 * 4"" assertion.